US 12297207
Maytansinoid derivatives, conjugates thereof, and methods of use
granted A61KA61K47/68033A61K47/6849
Quick answer
US patent 12297207 (Maytansinoid derivatives, conjugates thereof, and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K47/68033, A61K47/6849, A61K47/6889, A61P